Liquid Vaporizer Market 2021 Global Industry Size, Reviews, Segments, Revenue, and Forecast to 2027 – NeighborWebSJ – NeighborWebSJ

Fort Collins, Colorado: The most recently published Liquid Vaporizer Market report provides a critical assessment of key growth dynamics, emerging pathways, investment trends in key regional markets, and the competitive landscape in various regions and key players’ strategies. The study also offers insights into the proportion and size of various segments of the Liquid Vaporizer market. The report presents the market analysis based on several factors. Various exploration techniques such as qualitative and quantitative analysis have been used to accurately provide data. To better understand customers, he uses effective graphic presentation techniques such as charts, graphs, tables, and images.

Global Liquid Vaporizer Market to reach USD 7.5 billion by 2025. Global Liquid Vaporizer Market valued approximately USD XX billion in 2016 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026.

(Exclusive Offer: Flat 30% discount on this report)

Get | Download Sample Copy @

The report first introduced the fundamentals of the Liquid Vaporizer market: definitions, classifications, applications, and market overview, product specifications, manufacturing processes, cost structures, raw materials, etc. The report analyzes the main conditions of the world’s local business taking into account item cost, benefit, capacity, production, supply, demand, development rate, and advertising estimate, etc. Review.

The key insights of the report:

• The report provides important statistics on the market status of the Liquid Vaporizer manufacturers and is a valuable guidance and guidance tool for companies and individuals interested in the industry.
• The report provides a basic overview of the industry including definition, applications, and manufacturing technology.
• The report includes the company profile, product specifications, capacity, production value, and market share for major vendors for 2021-2027.
• The overall market is then further subdivided by company, country, and application/type for the competitive landscape analysis.
• The report estimates Liquid Vaporizer industry market development trends for 2021-2027.
• An analysis of the upstream raw materials, the downstream demand and the current market dynamics is also carried out

Request a Discount on the report @

The Following Companies are Major Contributors to the Liquid Vaporizer Market Research Report:

  • Enesis Group
  • Jyothi Laboratories
  • Coghlans Ltd.
  • Quantum Health
  • PIC Corporation
  • Godrej Consumer Products Limited
  • Reckitt Benckiser Group PLC
  • Spectrum Brand Holdings Inc
  • Dabur International

    Liquid Vaporizer Market Segmentation:

    By Type:

    • Atmospheric Pressure
    • Pressurized Pressure
    • Reduced Pressure

    By End-Use:

    • Mats
    • Cream & Oil
    • Coils
    • Liquid Vaporizer
    • Sprays/Aerosol

      Based on the Region:

      • North America (USA, Canada and Mexico)
      • Europe (Germany, France, Great Britain, Russia and Italy)
      • Asia Pacific (China, Japan, Korea, India, and Southeast Asia)
      • South America (Brazil, Argentina, Colombia, etc.)
      • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria, and South Africa)

      View market snapshot before purchasing @

      Liquid Vaporizer Market Report Comprises:

      • Liquid Vaporizer Market [Current market size forecast until 2027 with CAGR]
      • Regional breakdown [North America, Europe, Asia-Pacific, South America, and the Middle East and Africa]
      • Market Size Breakdown by Country [Major Countries With Significant Market Share]
      • Breakdown of Market Size by Type of Product / Service – []
      • Market Size by Application / Industry / End User – []
      • Market share and turnover/turnover of the top 10-15 market participants
      • If applicable, the production capacity of the main actors
      • Market Trends – New Technologies / Products / Startups, PESTEL Analysis, SWOT Analysis,
      • Porter’s Five Forces, etc.
      • Price Development – Average pricing across regions
      • Ranking by the brand of the most important market players in the world

      The report examines the details of Global Liquid Vaporizer Marketing and offers a detailed analysis of the various factors that promote or hinder the growth of the market. It relies on the most modern explanatory tools to measure openings by anticipating the actors. It also profiles the leading companies that work there and collects information about their income. Your item offers will be taken into account when deciding on the advertising department.

      Table of Contents:

      Part 01: Executive Summary

      Part 02: Scope of the Report

      Part 03: Research Methodology

      Part 04: Market Landscape

      Part 05: Pipeline Analysis

      Part 06: Market Sizing

      Part 07: Five Forces Analysis

      Part 08: Market Segmentation

      Part 09: Customer Landscape

      Part 10: Regional Landscape

      Part 11: Decision Framework

      Part 12: Drivers and Challenges

      Part 13: Market Trends

      Part 14: Vendor Landscape

      Part 15: Vendor Analysis

      Part 16: Appendix

      Request customization of the report @

      Customization of the Report:

      Please contact us if you would like more information about the report. If you have any special requirements and would like customization, please let us know. We will then offer the report as you wish.

      How Reports Globe is different than other Market Research Providers:

      The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

      Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

      Contact us:

      Mr. Mark Willams

      Account Manager

      US: +1-970-672-0390

      Email: [email protected]


      Sarkari Results, Thrive Market Research


    Virginia Lawmakers Send Cannabis Legalization Bill, With 2024 Start, to Governor’s Desk – Cannabis Wire

    After a thorough and steady push toward cannabis legalization, lawmakers in Virginia have sent adult use legislation to Governor Ralph Northam’s desk. As written, personal possession and home cultivation wouldn’t become legal until sales begin in 2024, and several provisions are set to be reconsidered in 2022. 

    Back in 2019, the state’s Attorney General Mark Herring kicked off conversations about cannabis reform, even hosting a cannabis summit to discuss everything from decriminalization to full adult use. By early 2020, decriminalization legislation was on Northam’s desk and signed into law. Shortly thereafter, a work group began to compile what would ultimately become a nearly 500-page report outlining recommendations for legalization. With that report in hand, in November, Northam called on lawmakers to pass legislation in 2021 to legalize cannabis for adult use. 

    And, that’s exactly what they’ve done. On Saturday, after some tense last-minute debate over key differences between the two versions of the adult use legislation, lawmakers narrowly approved SB 1406 and HB 2312, which would legalize cannabis possession and sales for adults 21 and older. Northam could outright sign the legislation, but he could also suggest amendments. 

    “The measure succeeding really is another step forward for cannabis justice in Virginia. There were extraordinary amounts of compromise involved in conference committee negotiations, and while the legislation is far from ideal, it does move the ball forward significantly,” NORML Development Director Jenn Michelle Pedini, who also serves as the Executive Director of Virginia NORML, told Cannabis Wire.

    “NORML’s top priority is to move earlier the date for legal possession and personal cultivation for adults 21 and older. These policy changes need not be tied to the date of retail sales, and we encourage those who agree to let Governor Northam know.”

    Indeed, one major sticking point came down to timing. While both bills set the start date for sales in 2024, the Senate aimed to make simple possession legal this year, while the House did not want simple possession legal until sales go live. Ultimately, lawmakers agreed that adults will not be able to legally possess or home grow cannabis until the enactment date, which is now January 1, 2024. Also, several parts of the legislation, for example, with regard to new penalties, will require “re-enactment,” which means that they would not move forward until lawmakers re-enact them by vote next year. 

    Other differences involved local control and licensing. The Senate wanted to allow localities to opt out, via referendum, of allowing cannabis shops. The House did not, but the Senate prevailed. And when it came to vertical integration, which allows an entity to hold licenses for everything from cultivation to sale, the House did not want to allow for it but the Senate did. Ultimately, it will be allowed for microbusinesses, and for existing medical cannabis shops, which are already vertically integrated, so long as they provide an equity plan and pay $1 million toward the state’s equity funds. 

    Several other cannabis-related bills are on the governor’s desk, including one that would allow for sales of cannabis flower to medical cannabis patients.

    If Gov. Northam signs the adult use legislation, a newly created Cannabis Control Authority will get to work this summer on crafting regulations for the new industry. And, Virginia would become the sixteenth state (and D.C.) to  legalize adult use cannabis.

    Cannabis would be taxed at 21%, which, with state and local taxes, would put the total rate at roughly 30%. Revenue would be allocated toward pre-kindergarten programs (40%), equity (30%), substance use programs and prevention (25%), and other public health efforts. 

    The legislation, which would give “preference” to social equity applicants in licensing, also establishes a Cannabis Equity Reinvestment Board that will oversee a Cannabis Equity Reinvestment Fund.

    In an interview with Cannabis Wire last year, AG Herring stressed that it was necessary for legalization to address the disproportionate rate of arrests between Black and white cannabis consumers, despite similar rates of use.

    Herring told Cannabis Wire that “the social equity and racial equity concerns are real in Virginia, and that disparity cannot be discounted or ignored. It has been proven, and legalization will help address that.”

    In January, Gov. Northam focused on equity when he spoke about legalization during his State of the Commonwealth address.

    “It’s time,” he said, to “make marijuana legal and end the current system rooted in inequity. We’ve done the research and we can do this the right way, leading with social equity, public health, and public safety.” 

    So, too, did Senator Adam Ebbin, one of the top backers of the legislation, who noted that a top priority for 2021 is to “create a legal adult-use market for cannabis that will equitably address the unfortunate impacts caused by the misguided war on marijuana.” 

    This Catalyst Could Lift Cannabis Stocks Out of Consolidation – New Cannabis Ventures

    You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.


    2021 has seen tremendous appreciation in cannabis stocks, but the past eleven trading sessions have left prices well below the peak on February 10th. The New Cannabis Ventures Global Cannabis Stock Index is up 50% in just the past 8 weeks, and this follows a 62% advance in Q4, but the index has declined almost 28% since February 10th:

    The strength since the end of the year can be attributed to the Democrats taking control of the Senate in early January following two runoff elections in Georgia. Investors have become excited by the prospects for federal legalization. Despite a substantial amount of equity offerings, strong investor demand, which includes institutions taking down some of these new issues, has helped the stocks to maintain most of their gains.

    In our view, the market got a bit ahead of itself (we warned our subscribers at 420 Investor at the end of the first week in February), but this recent pullback sets the stage for a potential advance in the coming weeks, especially for American operators, as they are poised to benefit from what we expect will be a very solid earnings season that kicks off when Curaleaf reports on March 9th. For a look at all of the currently scheduled releases, please consult the New Cannabis Ventures earnings calendar.

    We expect Q4 was yet another quarter of solid financial performance for the largest MSOs, with strong revenue growth and improving profitability, and investors are likely to be pleased. Taking a look at the leading MSOs by market cap and/or revenue using Sentieo as our data source, the typical MSO is expected to report year-over-year revenue growth of 112%.

    Of the 11 companies, six are expected to show acceleration from the prior quarter. Of the five that are expected to slow, all but one are still more than doubling revenue from a year ago. These numbers are likely to excite investors in our view.

    Like last quarter, we are hopeful that more companies will provide guidance for 2021. That wasn’t the case in November, with still only Jushi Holdings and TerrAscend guiding at this time. In an interview with New Cannabis Ventures in December, Curaleaf CEO Joseph Bayern stated that the company would provide 2021 guidance when it releases Q4 financials. Given that the company’s guidance is very likely to be in excess of $1 billion revenue (consensus is $1.26 billion), this could be a catalyst for the entire sector, as the media is likely to pick up on this potential milestone.

    Cannabis stocks have performed quite well in 2021 thus far, but this has been due primarily to political developments. We see Q4 earnings reports as a catalyst especially for MSOs, as investors are likely once again to be reminded of how robust industry growth is currently.

    For in-depth insights and analysis into the publicly-traded cannabis industry, there is no better source than Alan Brochstein’s 420 Investor premium service. Join the only due diligence platform trusted by cannabis investors for more than 7 years.

    New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:

    To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

    Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.

    Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.

    View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$12.5M per quarter.

    Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

    Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.


    Alan & Joel

    Alan Brochstein, CFA
    Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

    Get Our Sunday Newsletter

    El Dorado supervisors stick with existing cannabis ordinance – Tahoe Daily Tribune

    SOUTH LAKE TAHOE, Calif. — No new action was taken regarding the ordinance governing the personal use of cannabis at Tuesday’s El Dorado County Board of Supervisor’s meeting.

    Instead the board decided not to form a Cannabis Personal Use Ad Hoc Committee and will review the ordinance again next January once the county has more data.

    At present the ordinance allows adults 21 and older to have up to six cannabis plants for medicinal or recreational use per residence. Other regulations in the ordinance govern such things as screening, setbacks, odor control, security, residency requirements and property owner authorization.

    Because some users already planted their cannabis before final passage of the ordinance last year, county staff reported there was only limited enforcement of the ordinance through Dec. 1, 2020, as long as the cannabis was exclusively for personal medicinal use and was planted prior to May 6, 2020.

    Pointing out the benefits of the ordinance, deputy county counsel Breann Moebius noted it allows outdoor cultivation in all zones except multifamily residential. It recognizes the legitimate use of cannabis by those with medical needs but imposes a six-plant limit regardless of use. The ordinance provides clarity to the public and enforcement officials as to what is legal, which allows for expedited enforcement. It also aligns the county ordinance with the six-plant limit in Proposition 64 and the state’s position that a commercial license is required to grow more than six plants even for medicinal use. The ordinance will allow law enforcement officials to easily determine whether a personal cultivation grow is compliant.

    The existing ordinance also avoids use of square footage limits for outdoor cultivation and makes it easier to determine if a grow is in compliance with those limits. The ordinance also regulates regardless if the use of cannabis is for recreational or medical purposes and doesn’t require the county to implement an expensive “waiver” program tied to registration and fees. Last, Moebius said the ordinance provides an avenue to more effectively and safely combat the black market, which is necessary for the success of a legal market.

    Moebius noted El Dorado County’s climate is conducive to cultivating large marijuana plants. There are some 750 different types of marijuana strains available and each strain varies in size, levels of THC, levels of CBD, drought tolerance, etc. The average marijuana plant cultivated outdoors can yield conservatively 2-3 pounds of processed marijuana, the attorney said, and indoor marijuana plants have lower yields. A heavy marijuana user would smoke about 1.2 pounds of marijuana a year.

    At Tuesday’s meeting the board heard complaints from those not satisfied with the ordinance.

    Rod Miller, executive director of the El Dorado County Growers Alliance, provided a long list of complaints both verbally and in writing. He said the idea that all the grows in the county are run by organized crime was inaccurate and hyperbolic and that most of the grows raided were either legal before 2019 under the existing Medical Marijuana Program Act (Senate Bill 420) or were trying to comply with the rules in effect until December 2020.

    He also accused sheriff’s deputies of pointing AK-47s at families during searches of illegal grows, of ransacking people’s homes, destroying their greenhouses and taking cash and not returning it to its rightful owner. He repeatedly accused the El Dorado County Sheriff’s Office of deliberately not giving anyone a license and of refusing to follow the law regarding commercial cannabis growing. He also questioned if there is sufficient oversight of the sheriff’s department.

    In response Sheriff John D’Agostini said he agreed with staff that the county should hold off on forming a Cannabis Personal Use Ad Hoc Committee until after more data is collected as he accused Miller of being emotional rather than factual with the issue.

    To make his point, D’Agostini said last season the sheriff’s deputies served 263 search warrants for illegal grows. Those were approved by the District Attorney’s Office and signed by a judge. In over 75% of those cases, D’Agostini said the grows were tied to large-scale drug trafficking operations with ties to Mexico. The remaining ones, noted D’Agostini, were large, domestic illegal commercial grows. In only two cases where grows were eradicated were the owners trying to be in compliance with the ordinance and in those cases, no charges were filed, he added, saying on average the grows had 737 live plants.

    D’Agostini said other allegations by Miller were equally wrong as the department does not use AK47s because, in his words, “They are junk.” He said deputies do frequently carry rifles when serving criminal search warrants because it’s not unusual for them to find weapons. In the case of the cannabis warrants, deputies found 241 firearms, many of which were illegal assault weapons.

    The sheriff said searches did not involve ransacking property and that his office is not holding up background checks for licensing. As far as the allegations regarding cash assets being seized during searches, he said once a case is settled the cash goes to the DA’s Office or is returned to the owner. D’Agostini also noted there are multiple ways the public has oversight of his department, including submitting complaints, grand jury investigations or investigation by the state attorney general.

    In the discussion that followed Supervisors John Hidahl and Sue Novasel suggested bringing the issue back to the board in January for a review once they have more data and to discuss whether or not there is a need for an ad hoc committee. A motion to that effect was passed unanimously by the board.

    2 Cannabis Stocks That Could Be Millionaire Makers – The Motley Fool

    The legal marijuana market keeps growing as new U.S. states and other countries climb on the legalization bandwagon. Analysts from Grand View Research anticipate that the industry will grow at a compound annual rate of 18.1% through 2027, when it will reach a value of $73.6 billion. If one of your stocks were to grow at that rate for 15 years, then an initial investment of less than $83,000 would be enough to make you a millionaire.

    However, there is also plenty of risk in this sector, and investors could just as easily lose money in it if they choose poorly. In my view, to maximize your odds for success, the best investment options in the legal cannabis space today are Innovative Industrial Properties (NYSE:IIPR) and GrowGeneration (NASDAQ:GRWG)

    A marijuana plant is silhouetted against a sunset.

    Image Source: Getty Images.

    1. The case for Innovative Industrial Properties

    If you are looking for a safe way to profit from the legal marijuana business, Innovative Industrial Properties is a great option. The real estate investment trust (REIT) leases properties to growers under long-term contracts and generates strong profits that normally amount to more than 50% of its revenue. And while most REITs aren’t generally associated with growth, Innovative Industrial is different. It seeks out distressed cannabis assets that it can add to its portfolio and lease back to growers. Not only does it get great deals in the process, but it also adds to its recurring monthly income with each purchase.

    On Wednesday, Innovative Industrial released its fourth-quarter results, and it was another stellar performance. Revenue of $37.1 million for the quarter was more than twice the $17.7 million  generated in the prior-year period. Net income of $21 million rose by 120%. Management credited the growth primarily to acquisitions and new leases.

    Over the past 12 months, the REIT’s shares have risen by more than 80%. And in addition to that great capital appreciation, shareholders will also appreciate Innovative Industrial’s dividend, which yields 2.4% at current share prices — well above the S&P 500’s average of about 1.6%. Those payouts are likely to continue growing given the company’s strong financials and impressive track record. Since it went public in December 2016, it has hiked its payout nine times.

    With Innovative Industrial, you get a relatively safe pot stock with a business that’s both stable and growing.

    2. The case for GrowGeneration

    In the past 12 months, GrowGeneration stock has skyrocketed in value by about 800%. Had you invested $110,000 into it a year ago, you would already be sitting on a million-dollar position.

    GrowGeneration is a pick-and-shovel play, as it offers cannabis growers (and other indoor farmers) the tools they need to produce their crops, especially through the use of hydroponics. That’s a more complex system than conventional farming, relying on pumps, drip systems, and other components to make growing more efficient. However, it can save growers a ton of money, it takes up less space, and it doesn’t require soil. 

    Like Innovative Industrial Properties, GrowGeneration has been using acquisitions to accelerate its growth. On Feb. 23, it announced that it was acquiring San Diego Hydroponics & Organics, a company that owns four stores. Once those are added to its portfolio, GrowGeneration will operate 50 hydroponics and gardening stores throughout the country, including 17 in the world’s largest legal cannabis market — California. The company’s CEO has described Southern California as a „priority market for GrowGeneration,” and it’s hard to argue with that strategic emphasis. In 2020, California’s legal pot market generated $4.4 billion in sales, which was a 57% increase from the previous year.

    When GrowGeneration released its fourth-quarter and year-end results on Jan. 11, it posted impressive numbers of its own with sales of $192 million for all of 2020 — up 140% from 2019’s tally of $80 million. And while the company grew its business by adding 14 locations during the year, it also achieved strong organic growth; same-store sales rose by 63% year over year.

    Although California is GrowGeneration’s focus, the company still has many potential growth opportunities. New Jersey’s new recreational pot market could open for business in the coming months, and New York may legalize recreational use this year.

    With impressive gains behind it and lots of potential ahead, this is another growth stock that could over time make you a millionaire. 

    This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

    Finding The Best CBD Capsules & Soft Gels For Your Needs – The Fresh Toast

    ByNicole Richter

    CBD capsules are often marketed as being a modern and simplistic alternative to traditional CBD oil tinctures. They remove many of the factors that can put people off trying CBD supplements. As a result, they have quickly become one of the fastest-growing niches within the CBD industry.

    There are many reasons why people are increasingly looking for products like CBD capsules. There have been a number of studies focused on how regular use of CBD can help to improve both general health and even manage specific health issues.

    How Technology Is Reshaping The CBD Industry
    Photo by Pexels

    With an ever growing number of people turning to CBD supplements, including capsules, the industry has responded. Now, one can find a variety of CBD capsule options available across a range of online and retail markets.

    Knowing where to find the best CBD capsules and soft gels can feel a little daunting at first. We have put together a guide to some of the best CBD capsules on the market to help you discover the benefits of CBD supplements.

    #1 PureKana: Best for targeted effects

    PureKana has taken the idea of using CBD capsules as a general supplement one step further, offering a range of capsules designed for specific effects. PureKana CBD capsules include an immune boost capsule, AM caffeine capsule, and PM melatonin capsule.

    One of the things that PureKana has done really well is the ability to use different capsules throughout the day for a truly personalized CBD intake. Not only do the other capsules available trigger slightly different effects, but they also contain varying amounts of CBD tailored to match their effects.

    RELATED: 5 Of The Most Popular Ways To Take CBD

    There are currently four different capsules to choose from, providing a range of different combinations and effects to match an individual’s specific and health goals. PureKana’s general purpose CBD capsules are also available in two different strengths for daily, all-around support.

    #2 Premium Jane: Fast-acting CBD soft gels

    Premium Jane has two different strength CBD soft gels to choose from, and both offer the brand’s high quality organic formula. Premium Jane has become a popular CBD brand thanks to their continued commitment to only using the very best organic ingredients possible.

    Using their rich full-spectrum CBD blend, Premium Jane has crafted both 25mg and 40mg soft gels options giving their customers control over the amount of CBD they consume at any one time. By using full-spectrum CBD, Premium Jane has been able to pack a healthy and natural blend of cannabinoids and terpenes into each fast-acting soft gel.

    #3 Provacan: Best full-spectrum CBD capsules

    Provacan is known for their simplistic approach to CBD, working to create products that deliver effective results using as few ingredients as possible. One of Provacan’s CBD capsules’ defining features is that they offer an experience remarkably similar to their CBD oil tinctures.

    RELATED: A Beginner’s Guide To Buying CBD Products

    Provacan CBD capsules are made using the same base formula as their tinctures, meaning the two products can be used interchangeably. Across both oils and capsules, Provacan uses their rich Cannabis Sativa (L) extract, which retains all of the healthy cannabinoids found within hemp plants.

    Israeli Firm Says Medical Marijuana Best Taken In Microdosing Format
    Photo by Esther Kelleter/EyeEm/Getty Images

    The HPMC capsules coating used in all of Provacan’s capsules ensures a smooth experience with each use. Provacan’s capsules are great for both those who are used to CBD capsules, as well as anyone looking to try them for the very first time.

    Committed to making their products as accessible as possible, Provacan has three different strength options to choose from: starting with their 180mg capsules and working up to a much stronger 2880mg of CBD, Provacan ensures that everyone can experience and benefit from their CBD capsules.

    #4 CBD FX: Best broad-spectrum CBD capsules

    CBD FX’s capsules provide the perfect balance between CBD isolate and full-spectrum CBD. By choosing to use broad-spectrum in their capsules, CBD FX is able to offer all of the essential healthy cannabinoids found within hemp plants without the extra compounds (namely THC) that tend to occur with full-spectrum products.

    CBD FX only uses two additional ingredients to create their CBD capsules: MCT oil and gelatin. This results in a very natural final product. Also, the smooth coating helps to ensure that CBD FX capsules can be taken quickly and with ease.

    RELATED: What Are The Benefits Of Full-Spectrum Cannabis Extracts?

    Customer trust and transparency are essential at CBD FX, and that is why they make all of the third party lab test results accessible to their customers while shopping. These reports provide essential information, including the exact cannabinoids and terpenes which can be found within CBD FX capsules.

    #5 Joy Organics: Best CBD Isolate capsules

    Joy Organics Everyday Formula Soft Gels are the perfect solution when looking for a CBD isolate capsule. Joy Organics guarantees that their soft gel capsules contain 0% THC, and they come with lab analysis reports to prove it.

    Each Joy Organics soft gel is made using their unique water-soluble nanoemulsion technology, which both increases bioavailability and makes them easy to swallow. Each capsule contains exactly 25mg of pure, third party tested CBD isolate for effective results that can be enjoyed daily.

    This article originally appeared on Green Market Report and has been reposted with permission.

    Wynonna Judd Launches CBD Product Line – Williamson Source

    Wynonna Judd
    photo from Wynonna Judd CBD

    Country music icon, Wynonna Judd, has partnered with Nashville-based CeleBriDy Brands to develop WYNONNA CBD. Custom formulated to the specifications of the Country music queen herself, WYNONNA CBD is a luxurious new line of herbal-infused hemp-derived products designed to help bring harmony to your everyday life.

    WYNONNA CBD offers premium hemp extract oil, topical balm, and luxurious bath bombs, all made using organic extracts from hemp grown in the USA and responsibly sourced, all-natural ingredients. Manufactured in Nashville, Tennessee, WYNONNA CBD’s hemp extract is infused with a soothing and harmonious blend of vanilla and lavender to promote balance and relaxation. The balm features a blend of essential oils, hemp extract, and Vitamin E, designed to provide topical relief day or night.

    “We need to relax, we need balance,” says Wynonna. “Everybody’s just processing a lot of stuff. I’m constantly talking about my own healing and recovery process. I was famous at 18, I’m an introvert, and I’ve battled anxiety since the beginning of the Judds. We finally found something that works for me and I want my fans to benefit as well.”

    “We are thrilled to partner with Wynonna Judd,” says CeleBriDy Brands founder Brian Mayes. “Wynonna is not just a legendary artist, but a trusted friend to fans worldwide. She has shared her life with them for nearly four decades, and they trust her. And that is why it was imperative that we create a premium product that is worthy of her name. Wynonna put her personal touch on WYNONNA CBD products from start to finish, and we know they will help people tune in to themselves and the things that really matter.”

    WYNONNA CBD is available exclusively at

    Offers for you

    Support our publication by shopping here

    Get a debit card for your kids, managed by you

    Raise financially-smart kids with a card that lets you control how they use it.

    Coding for kids.

    Introducing programming games for the next generation.

    Four cannabis bills jockey for approval – Albuquerque Journal

    Copyright © 2021 Albuquerque Journal

    SANTA FE – With three weeks to go in New Mexico’s 60-day legislative session, the outlook for adult-use cannabis legalization remains hazy at best.

    But backers of four legalization bills still in the mix at the Roundhouse expressed optimism Saturday that a compromise measure – likely a mashup of the various proposals – could move forward and reach Gov. Michelle Lujan Grisham’s desk before the legislative session ends.

    Rep. Javier Martínez

    A Senate committee spent more than three hours Saturday scrutinizing the bills but did not vote on them, instead directing bill sponsors to try to hash out their differences over the next week.


    “I think we’ve got plenty of time,” Rep. Javier Martínez, D-Albuquerque, said in an interview after the hearing, citing a bipartisan willingness to work on a marijuana legalization bill after years of debate on the subject. “We’re feeling really good.”

    The Senate Tax, Business and Transportation Committee discussion came one day after the House voted 39-31 to approve a legalization bill sponsored by Martínez and others that would authorize commercial sales to begin in January 2022.

    That bill, House Bill 12, could be amended in the Senate and then advanced, which would avoid the need for House committees to vote on it again, said Senate Majority Leader Peter Wirth, D-Santa Fe.

    However, several Republicans suggested they would not support the House-approved bill in its current form and prefer other approaches to cannabis legalization.

    “I think it’s time to end prohibition, but there are things that have to be in there – or not in there – for me to (vote to) do it,” said Senate Minority Whip Craig Brandt, R-Rio Rancho.

    Indeed, while a growing number of New Mexico lawmakers appear to see legalization of recreational cannabis as imminent, several issues are still being debated.

    Details scrutinized Saturday included tax rates, water rights, revenue uses, personal production limits and regulation of a new legal marijuana industry.

    The tax rates in the four bills under consideration would range from 12% to 21%, with most of the generated revenue going to the state and a smaller amount to cities and counties.

    Sen. Cliff Pirtle, R-Roswell, sponsor of one of the four bills, Senate Bill 288, said an excessively high tax rate could lead many to continue to buy cannabis on the black market.

    Sen. Cliff Pirtle

    “We don’t want to put the tax rate so high … that we tax the legal cannabis out of the market,” Pirtle said.

    Sen. Jacob Candelaria, D-Albuquerque, said there should be no cap on plants or licenses for producers, adding that existing plant count limits in the state’s medical cannabis program have led to chronic supply shortages.

    He also said he envisions New Mexico eventually exporting cannabis products, though such interstate commerce would hinge on federal legalization of cannabis.

    “You don’t get your green chile from New Jersey,” Candelaria said. “Why get your cannabis from anywhere else than New Mexico?”

    Sen. Jacob Candelaria

    New Mexico would become the 16th state to legalize recreational cannabis if a bill is signed into law this year by Lujan Grisham, who supports doing so as long as legislation includes safeguards for children and medical cannabis users.

    And recent polls have shown support across all regions of New Mexico for legalizing recreational marijuana use and taxing its sales.

    “We simply cannot afford to wait another year,” said Rep. Tara Lujan, D-Santa Fe, citing recent cannabis-related laws in several neighboring states, including Arizona, where voters approved a legalization referendum last year.

    But some lawmakers remain skeptical in a state with one of the nation’s highest drug overdose rates.

    Sen. Michael Padilla, D-Albuquerque, shared the story of an individual close to him who died at a young age after starting to smoke marijuana as a teenager.

    He also asked questions about possible political interference within a proposed cannabis regulatory board that would be established under several of the bills to oversee the industry.

    The 60-day legislative session ends March 20.

    Cannabis could bring new funds, challenges to Santa Fe – Santa Fe New Mexican

    It appears New Mexico is primed to get its share of the so-called green rush.

    While a movement to legalize cannabis for recreational adult use has been gaining steam for years, proponents believe a bill is likely to reach the desk of Gov. Michelle Lujan Grisham, who supports the effort, during the current legislative session.

    What would legalized cannabis mean for Santa Fe?

    While the city would stand to see an increase in tax revenues and job creation through legalization, it also would have to contend with zoning changes and develop strategies for law enforcement to detect drivers impaired by marijuana.

    Much depends on what legislation is approved. Each of several bills introduced in the Legislature has its own framework for a legalization, including the potential for local municipalities to impose taxes.

    Legislation with the most momentum, House Bill 12, passed the House floor Friday and moved to the Senate. If that bill was signed into law, recreational sales would begin Jan. 1.

    The bill would allow for a 20.4 percent tax ceiling on cannabis, with a state excise tax of 8 percent. Local governments could impose taxes up to 4 percent. According to some estimates, the bill would generate around $24 million a year for some local governments and $44 million for the state, though a fiscal impact report put the figures closer to $15 million for the state and $8 million for local governments.

    Emily Kaltenbach, state director of the Drug Policy Alliance, which backs HB 12, said cities and counties shouldn’t expect to make a windfall on cannabis, but legalization could mean more money for cash-strapped programs.

    “There is a huge benefit to local jurisdictions to legalization because they will receive additional funding that they have not received in the past and the freedom to use them in whatever way they see as useful in their communities,” she said.

    Santa Fe City Councilor Signe Lindell said the prospect of more funds during a period when the city is dealing with lost revenue during the coronavirus pandemic is an attractive proposition.

    “We have plenty of places to spend it,” Lindell said. “We have a hole to dig out of. I hope those are discussions we can have.”

    Councilor Michael Garcia said he doesn’t expect the city to see a massive revenue increase from recreational cannabis, but thinks officials need to begin discussing where the city should invest any potential revenue.

    He tossed out ideas like affordable housing, substance abuse prevention and mental health programs as possible landing spots for funds.

    “We want to look at the revenues closely and strategically,” Garcia said. “Where will it have the most impact?”

    Affordable housing is an area Councilor JoAnne Vigil Coppler also would like to see explored if cannabis is legalized.

    “I think it would be a good healthy cash flow,” Vigil Coppler said. “We’ll have to think about: Where are our needs, where does the money need to be best put to use and what are the city’s issues?”

    Kaltenbach said she sees legalization as an opportunity to help address the impact of cannabis prohibition on disadvantaged communities.

    “Legalization not only needs to fix the present and the future, but also repair the harm from the past,” Kaltenbach said.

    While the taxes gained would be a big get, Ben Lewinger, executive director of the New Mexico Cannabis Chamber of Commerce, which backs House Bill 17, a bill that has been tabled by a House committee, said another factor for cities to consider is the business opportunities the cannabis industry would spawn.

    Legalization is expected to generate 11,000 jobs across the state directly tied to cannabis, but Lewinger expects it would create far more jobs, which he said could drive additional revenue to cities and business owners.

    “All of this adjacent cannabis-related infrastructure is going to have the ability to grow in this new industry, doing the business they already do, just in a new industry,” Lewinger said.

    Construction companies, marketing firms and agriculture-related businesses could find new clientele in a budding cannabis industry, Lewinger said.

    Len Goodman was one of the first New Mexicans to receive a license to produce medical cannabis in 2007, and he said he expects more dispensaries to spring up across the city after legalization. But whether those dispensaries could survive the long haul remains a question mark.

    Currently, about 12 medical dispensaries are spread across Santa Fe, with another three in the pipeline, which Goodman said is probably already more than the city can support.

    “That is the nature of the free market,” Goodman said. “More stores want to open up. It’s going to push people out of the business. Some will do well; some will do worse. The only potential control is from a zoning perspective.”

    Lewinger agreed, noting the control for cities largely is how they approach zoning to steer where recreational cannabis businesses can open.

    “There is a lot of local control through local zoning ordinances,” Lewinger said.

    Lindell said the city has a “fair amount of work ahead of it,” on working out a zoning plan if recreational cannabis is legalized.

    “Of course, we don’t have anything in the current code,” Lindell said. “That will be a whole new issue. It will require a fair amount of discussion.”

    A study hasn’t been completed on how the city might approach recreational cannabis, but one should be done in the future if a bill is signed into law, said Councilor Chris Rivera.

    “I try to look at everything from a broad perspective,” Rivera said. “On the economic side, it’s clearly going to benefit the city to have that extra income coming in. On the bad side, we don’t know what the effects on the public would be driving. How many people would be using it.

    “It would still be illegal at the federal level, which has caused some issues in Colorado.”

    Santa Fe County Sheriff Adan Mendoza shares similar concerns. He said his chief question is how recreational cannabis might impact the rates of people driving while intoxicated. He noted there are no tools to accurately determine whether a driver is under the influence of marijuana.

    “Alcohol, they have machines. You can do things like roadside tests,” Mendoza said. “I would hope that those issues would all be ironed out before they put the cart before the horse, so to speak.”

    There also is no standard level of impairment for marijuana, as opposed to alcohol, which has a set blood-alcohol content drivers are prohibited from exceeding or face charges.

    Mendoza said there is drug detection training for law enforcement, but offering such training to an entire force comes at a high cost.

    “It’s a difficult science, so it’s not something you can just train a whole police force on,” Mendoza said. “It’s not fiscally possible to do that.”

    The Santa Fe Police Department declined to comment.

    Garcia said his main focus is to make sure Santa Fe approaches a potential new cannabis industry in a safe manner.

    “I think it’s a step in the right direction,” Garcia said. “What needs to be ensured is that should cannabis be legalized, it’s practiced in a safe manner.”